EUVIMEDEUVIMED entdecken
Crossref

Denosumab for the Treatment of Bisphosphonate-Refractory Hypercalcemia of Malignancy

Vishal V Ramteke, Sudhir Ranjan Dash, Shubhadeep Bose, Ritu Jain

Journal of Urology and Renal Diseases · 2016

DOI: 10.29011/2575-7903.000109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Urology and Renal Diseases, 2016. Verfasst von Vishal V Ramteke und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ramteke, V. V., Dash, S. R., Bose, S., & Jain, R. (2016). Denosumab for the Treatment of Bisphosphonate-Refractory Hypercalcemia of Malignancy. Journal of Urology and Renal Diseases. https://doi.org/10.29011/2575-7903.000109

Vancouver

Ramteke VV, Dash SR, Bose S, Jain R. Denosumab for the Treatment of Bisphosphonate-Refractory Hypercalcemia of Malignancy. Journal of Urology and Renal Diseases. 2016. doi:10.29011/2575-7903.000109

BibTeX
@article{Ramteke2016,
  author = {Ramteke, Vishal V and Dash, Sudhir Ranjan and Bose, Shubhadeep and Jain, Ritu},
  title = {Denosumab for the Treatment of Bisphosphonate-Refractory Hypercalcemia of Malignancy},
  journal = {Journal of Urology and Renal Diseases},
  year = {2016},
  doi = {10.29011/2575-7903.000109}
}
Kostenlos starten →